| vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 met recombinant-eiwitvaccin van 'spike'-antigeen (verrichting) |
| vaccinatie tegen SARS-CoV-2 met recombinant-S-eiwitvaccin |
| toedienen van vaccin met recombinant-S-eiwit tegen COVID-19
actieve immunisatie met recombinant-'spike'-eiwit van SARS-CoV-2
vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 met recombinant-eiwitvaccin van 'spike'-antigeen
|
| Administration of SARS-CoV-2 recombinant spike protein antigen vaccine |
| COVID-19 recombinant spike protein antigen vaccination
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen
2019-nCoV recombinant spike protein antigen vaccination
2019 novel coronavirus recombinant spike protein antigen immunization
2019-nCoV recombinant spike protein antigen immunization
Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccination
COVID-19 recombinant spike protein antigen immunization
SARS-CoV-2 recombinant spike protein antigen immunization
SARS-CoV-2 recombinant spike protein antigen vaccination
2019 novel coronavirus recombinant spike protein antigen vaccination
|
